BIOCRYST PHARMACEUTICALS INC Quarterly Current Ratio in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Biocryst Pharmaceuticals Inc quarterly Current Ratio history and growth rate from Q1 2012 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Current Ratio for the quarter ending September 30, 2024 was 314 %, a 41.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 314 -225 -41.8% Sep 30, 2024
Q2 2024 369 -185 -33.4% Jun 30, 2024
Q1 2024 431 -116 -21.2% Mar 31, 2024
Q4 2023 477 -82 -14.7% Dec 31, 2023
Q3 2023 539 -36.4 -6.33% Sep 30, 2023
Q2 2023 554 +113 +25.6% Jun 30, 2023
Q1 2023 547 +179 +48.7% Mar 31, 2023
Q4 2022 559 +260 +86.9% Dec 31, 2022
Q3 2022 575 +331 +135% Sep 30, 2022
Q2 2022 441 +205 +86.8% Jun 30, 2022
Q1 2022 368 +139 +60.8% Mar 31, 2022
Q4 2021 299 +102 +51.4% Dec 31, 2021
Q3 2021 245 +80.5 +49% Sep 30, 2021
Q2 2021 236 +81.5 +52.6% Jun 30, 2021
Q1 2021 229 +89.5 +64.3% Mar 31, 2021
Q4 2020 198 +49.1 +33% Dec 31, 2020
Q3 2020 164 +21.3 +14.9% Sep 30, 2020
Q2 2020 155 -15.8 -9.27% Jun 30, 2020
Q1 2020 139 -25.9 -15.7% Mar 31, 2020
Q4 2019 149 -6.66 -4.29% Dec 31, 2019
Q3 2019 143 -13.1 -8.41% Sep 30, 2019
Q2 2019 171 +1.12 +0.66% Jun 30, 2019
Q1 2019 165 -13.4 -7.52% Mar 31, 2019
Q4 2018 155 -38.5 -19.9% Dec 31, 2018
Q3 2018 156 -29.8 -16% Sep 30, 2018
Q2 2018 169 +18.4 +12.2% Jun 30, 2018
Q1 2018 179 +46.6 +35.3% Mar 31, 2018
Q4 2017 194 +92.3 +91.1% Dec 31, 2017
Q3 2017 186 +89.3 +92.5% Sep 30, 2017
Q2 2017 151 +51.5 +51.7% Jun 30, 2017
Q1 2017 132 +11.4 +9.44% Mar 31, 2017
Q4 2016 101 -32.1 -24.1% Dec 31, 2016
Q3 2016 96.5 -49.9 -34.1% Sep 30, 2016
Q2 2016 99.5 -77.9 -43.9% Jun 30, 2016
Q1 2016 121 -87 -41.9% Mar 31, 2016
Q4 2015 133 -107 -44.5% Dec 31, 2015
Q3 2015 146 -137 -48.4% Sep 30, 2015
Q2 2015 177 -125 -41.3% Jun 30, 2015
Q1 2015 208 -84.9 -29% Mar 31, 2015
Q4 2014 240 -64.9 -21.3% Dec 31, 2014
Q3 2014 284 -9.9 -3.37% Sep 30, 2014
Q2 2014 302 +5.24 +1.77% Jun 30, 2014
Q1 2014 293 +11.8 +4.22% Mar 31, 2014
Q4 2013 305 +18.5 +6.46% Dec 31, 2013
Q3 2013 294 +27.5 +10.3% Sep 30, 2013
Q2 2013 297 +35.6 +13.6% Jun 30, 2013
Q1 2013 281 -13.2 -4.48% Mar 31, 2013
Q4 2012 287 Dec 31, 2012
Q3 2012 266 Sep 30, 2012
Q2 2012 261 Jun 30, 2012
Q1 2012 294 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.